Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used for bowel cleansing prior to colonoscopy, surgery, or diagnostic procedures. It works by drawing water into the colon, which softens stool and stimulates bowel evacuation.
## Primary Indications
* Bowel preparation for colonoscopy, sigmoidoscopy, or barium enema.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 fl oz (133 mL) bottle administered as a single dose. The exact timing and administration instructions should follow specific protocol or physician guidance. Some protocols may recommend a second dose.
* **Constipation:** One 2.25 fl oz (67 mL) bottle administered as a single dose.
## Pediatric Dosing
* **Children 2 to under 12 years:** One-half the adult dose (2.25 fl oz or 67 mL bottle).
* **Children under 2 years:** Not recommended. Safety and efficacy have not been established. Use with extreme caution and only under strict medical supervision if deemed necessary, with doses determined by a physician.
## Dose Adjustments
No specific dose adjustments are typically required based on renal or hepatic impairment, but caution is warranted due to the risk of electrolyte imbalances.
## Contraindications
* Congenital or acquired megacolon.
* Abnormalities of the gastrointestinal tract (e.g., intestinal obstruction, stenosis, Hirschsprung's disease).
* Heart failure, severe renal impairment, or congestive heart failure.
* Patients with impaired gastrointestinal motility.
* Children under 2 years of age.
* Patients on medications that affect the gastrointestinal tract or fluid/electrolyte balance.
* Patients with anuria or history of sodium phosphate-induced phosphate nephropathy.
* Use in patients with ileostomy or colostomy is generally contraindicated due to risk of significant fluid and electrolyte disturbances.
## Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, rectal irritation, bloating.
* **Serious:**
* **Electrolyte disturbances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia, metabolic acidosis. These can lead to seizures, cardiac arrhythmias, renal failure, and death, especially with overuse, rapid administration, or in susceptible patients.
* **Renal toxicity:** Acute kidney injury, phosphate nephropathy.
* **Dehydration.**
* **Hypersensitivity reactions.**
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalances.
* **ACE inhibitors/ARBs:** Increased risk of hyperkalemia.
* **Calcium channel blockers:** Potential for increased risk of hyperkalemia.
* **NSAIDs:** May increase the risk of renal impairment.
* **Laxatives:** Concurrent use may potentiate dehydration and electrolyte disturbances.
## Monitoring
* **Fluid and electrolyte status:** Monitor serum electrolytes (phosphate, calcium, sodium, potassium) and renal function (BUN, creatinine), especially in patients at risk for imbalances.
* **Renal function:** Assess renal function prior to and after use, particularly in those with pre-existing renal disease or risk factors.
* **Signs of dehydration:** Monitor for dizziness, decreased urine output, and thirst.
## Clinical Pearls
* Administer slowly to minimize cramping and discomfort.
* Instruct patients to retain the enema for the recommended time (usually 5-15 minutes) to ensure efficacy.
* Ensure adequate oral hydration before and after administration.
* Avoid concurrent use with other sodium phosphate preparations (oral or rectal) or other laxatives to prevent overdose and severe electrolyte disturbances.
* Use with extreme caution in elderly, debilitated, or renally impaired patients.
* The risk of severe complications is significantly higher in children and in patients with contraindications.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions.*
